These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12952392)

  • 1. Enhanced antitumour activity of 15-residue bovine lactoferricin derivatives containing bulky aromatic amino acids and lipophilic N-terminal modifications.
    Eliassen LT; Haug BE; Berge G; Rekdal O
    J Pept Sci; 2003 Aug; 9(8):510-7. PubMed ID: 12952392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin-derived peptide.
    Yang N; Lejon T; Rekdal O
    J Pept Sci; 2003 May; 9(5):300-11. PubMed ID: 12803496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives.
    Haug BE; Skar ML; Svendsen JS
    J Pept Sci; 2001 Aug; 7(8):425-32. PubMed ID: 11548058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
    Haug BE; Svendsen JS
    J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
    Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
    J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides.
    Lejon T; Svendsen JS; Haug BE
    J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a direct antitumor mechanism of action of bovine lactoferricin.
    Eliassen LT; Berge G; Sveinbjørnsson B; Svendsen JS; Vorland LH; Rekdal Ø
    Anticancer Res; 2002; 22(5):2703-10. PubMed ID: 12529985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
    Farnaud S; Patel A; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of 15-residue lactoferricin derivatives.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-papillomavirus activity of human and bovine lactoferricin.
    Mistry N; Drobni P; Näslund J; Sunkari VG; Jenssen H; Evander M
    Antiviral Res; 2007 Sep; 75(3):258-65. PubMed ID: 17481742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
    Haug BE; Andersen J; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells.
    Roy MK; Kuwabara Y; Hara K; Watanabe Y; Tamai Y
    J Dairy Sci; 2002 Sep; 85(9):2065-74. PubMed ID: 12362437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of NMR structures and model-membrane interactions of 15-residue antimicrobial peptides derived from bovine lactoferricin.
    Jing W; Svendsen JS; Vogel HJ
    Biochem Cell Biol; 2006 Jun; 84(3):312-26. PubMed ID: 16936802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.
    Horvat S; Mlinarić-Majerski K; Glavas-Obrovac L; Jakas A; Veljković J; Marczi S; Kragol G; Roscić M; Matković M; Milostić-Srb A
    J Med Chem; 2006 Jun; 49(11):3136-42. PubMed ID: 16722632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-complement effects of lactoferrin-derived peptides.
    Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amino acid substitutions on the candidacidal activity of LFampin 265-284.
    van der Kraan MI; van der Made C; Nazmi K; van't Hof W; Groenink J; Veerman EC; Bolscher JG; Nieuw Amerongen AV
    Peptides; 2005 Nov; 26(11):2093-7. PubMed ID: 15946771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin.
    Nguyen LT; Schibli DJ; Vogel HJ
    J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity of aromatic camptothecin esters.
    Cao Z; Mendoza J; Dejesus A; Vardeman D; Giovanella B
    Int J Mol Med; 2008 Apr; 21(4):477-87. PubMed ID: 18360694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.